Stock SLS SELLAS LIFE SCIENCES GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Market Closed - Nasdaq
Other stock markets
 20:59:51 29/05/2024 BST 		5-day change 1st Jan Change
1.35 USD -2.17% Intraday chart for SELLAS Life Sciences Group, Inc. -5.59% +27.36%
05-19 Certain Common Stock of SELLAS Life Sciences Group, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024. CI
05-01 SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SELLAS LIFE SCIENCES GROUP, INC. Stock SELLAS Life Sciences Group, Inc.
 77.97M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
BIONTECH SE Stock BioNTech SE
 22.5B -
ARGENX SE Stock argenx SE
 22.57B -
GENMAB A/S Stock Genmab A/S
 17.95B
  1. Stock Market
  2. Equities
  3. SLS Stock
  4. Charts SELLAS Life Sciences Group, Inc.
  5. Sector Chart